Dr. CHEN Guolan (Lane)陈国蓝 博士 (Lane)

Lane CHEN is a serial entrepreneur who has founded three health-technology companies — two in Hong Kong, 2HEALTH AI LIMITED and Gene to Health Limited, and one in Guangzhou, CHONPS Health Tech Ltd. As Founder & CEO of the Hong Kong ventures he is building a multi-omics, big-data and AI-driven, full-life-cycle human-health digital twin platform: an end-to-end ecosystem integrating disease prediction, proactive prevention, and personalized health management. He holds a BSc in Biological Sciences from Fudan University and is completing his PhD in Statistical Genetics & Machine Learning at The University of Hong Kong, supervised by Prof. Pak-Chung Sham — a world-renowned geneticist and national-level talent. His research spans polygenic risk prediction, Mendelian Randomization, and statistical-genetics methodology, with first- / corresponding-author publications in journals including Psychological Medicine and Statistics in Medicine. He has led his teams to secure support from the HKSTP Incubation Program and the Greater Bay Area Youth Entrepreneurship funding, along with multiple Hong Kong innovation & entrepreneurship awards. He now drives the companies' product development, R&D, and international commercialization with steady, continuous progress. 陈国蓝是一名连续创业者,先后创立三家健康科技公司——香港的 2HEALTH AI LIMITED 与基因智健(Gene to Health Limited),以及广州的创思健康科技(CHONPS Health Tech Ltd.)。作为两家香港公司的创始人兼 CEO,致力于打造多组学大数据与 AI 驱动的全生命周期人类健康数字孪生平台,构建集成疾病预测、主动预防与个性化健康管理的全链条生态。本人拥有复旦大学生物科学学士学位,已完成学业即将取得香港大学统计遗传学与机器学习博士学位(师从世界知名遗传学家、国家级人才沈柏松教授)。研究方向涵盖多基因风险预测、孟德尔随机化与统计遗传学方法学,以第一 / 通讯作者身份在 Psychological Medicine、Statistics in Medicine 等发表论文。本人带领团队获得香港科技园孵化计划、粤港澳大湾区青年创业资助等支持及多项香港创新创业奖项。现主导公司的产品开发、技术研发与国际化商业化拓展,取得持续进步的成绩。

Innovation & entrepreneurship awards / grants below as team leader / principal applicant.以下创新创业奖项 / 资助均以团队负责人 / 主要申请人身份获得。